Independent reference. Not affiliated with, endorsed by, or speaking for the U.S. Food and Drug Administration.
FDA Medication Tracker

← All approvals · Infections & vaccines · 2024

Exblifep (cefepime, enmetazobactam)

The FDA approved Exblifep (cefepime, enmetazobactam) on February 22, 2024 to treat complicated urinary tract infections.
Brand name
Exblifep
Generic name
cefepime, enmetazobactam
FDA approval date
February 22, 2024
Approved use (FDA wording)
To treat complicated urinary tract infections
Category on this site
Infections & vaccines

Official sources

Facts only. This site lists what the FDA has approved and what the FDA says each drug is approved for, quoted or closely paraphrased from FDA and openFDA records. It gives no medical advice, no dosing, and no comparisons, and it says nothing about whether a drug is right for anyone. Talk to a licensed clinician about any medication. Records can lag or contain errors; the FDA's own pages are authoritative.